IT Versione italiana

up-dating events » New Opening for Psoriasis Management 2013 - by IBSA Genevrier

New Opening for Psoriasis Management 2013 - by IBSA / Genevrier

The advantages of a medicated plaster containing betamethasone valerate 0,1% in psoriasis treatment are becoming more and more evident.  In depth discussions, benchmark results and clinical cases have been the focus of the symposium "New Opening for Psoriasis Management in 2013", sponsored by IBSA / Genevrier, during the 4th Congress of the Psoriasis International Network, held in Paris from the 4th to the 6th of July 2013.  Thanks to this state of the art medicated plaster, the patient will be able to treat the lesion in a fuss-free and functional way, also avoiding the risks of corticosteroid over-dosage which can easily occur when using corticosteroids contained in traditional formulations.  Full patient compliance is also guaranteed thanks to an important technological innovation which releases the active ingredient throughout the 24h of application.


clinical cases

patients associations

Cookies helps us to provide our services. Using these services , you agree to use of cookies on our part. OK